HRT Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-6,600
Closed -$400K – 4249
2026
Q1
$400K Sell
6,600
-4,300
-39% -$251K ﹤0.01% 2684
2025
Q4
$587K Buy
+10,900
New +$524K ﹤0.01% 2021
2020
Q3
– Sell
-20,800
Closed -$1.22M – 1904
2020
Q2
$1.22M Buy
+20,800
New +$1.24M 0.04% 485

Other funds holding BMY

HRT Financial's BMY Position: Q2 2026 in Review

HRT Financial reduced its Bristol-Myers Squibb (BMY) stake by 64% in Q2 2026, selling an estimated $76.6M and leaving 741,187 shares worth $42.7M. The position accounts for 0.08% of the portfolio, ranked #239.

HRT Financial first reported a position in BMY in Q4 2014 and has held it in 17 quarters since. The position peaked at $126M in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • HRT Financial held 741,187 shares of Bristol-Myers Squibb worth $42.7M as of Q2 2026.
  • HRT Financial sold 1,334,758 Bristol-Myers Squibb shares in Q2 2026, an estimated $76.6M.
  • Bristol-Myers Squibb made up 0.08% of HRT Financial's portfolio in Q2 2026, its #239 holding.
  • HRT Financial first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 17 quarters since.
  • HRT Financial's Bristol-Myers Squibb position peaked at $126M in Q1 2026.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.